Skip to main content
ZIM Laboratories Limited logo

ZIM Laboratories Limited — Investor Relations & Filings

Ticker · ZIMLAB ISIN · INE518E01015 LEI · 335800YPYG1O3ML66R52 BSE.NS Manufacturing
Open in API
Filings indexed 423 across all filing types
Latest filing 2023-10-21 Regulatory Filings
Country IN India
Listing BSE.NS ZIMLAB

About ZIM Laboratories Limited

https://www.zimlab.in/

ZIM Laboratories Limited is a research-driven organization specializing in the development and manufacturing of innovative drug delivery solutions. The company focuses on enhancing the efficacy and patient compliance of generic medicines through advanced formulation technologies. Its core product portfolio includes Oral Disintegrating Films (ODF), Oral Disintegrating Tablets (ODT), pellets, and taste-masked granules. Utilizing proprietary technology platforms like Thinoral, the company provides differentiated products across various therapeutic segments, including central nervous system, cardiovascular, and gastrointestinal health. ZIM Laboratories offers end-to-end services from product development and clinical trials to commercial manufacturing. The organization serves a global clientele, providing value-added generic formulations that address specific patient needs such as ease of administration and rapid onset of action.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Regulatory Filings
2023-10-21 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the loss of a share certificate and the subsequent stop transfer of shares until a duplicate certificate is issued. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 39(3). The content is about share certificate loss and stop transfer instructions, which is a regulatory compliance notification related to share transactions but not a financial report, earnings release, or management information. It is not a report publication announcement or certification. This fits best under the category of Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit other specific categories like Director's Dealing or Share Issue/Capital Change.
2023-10-20 English
Updates
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges regarding the incorporation of a step-down subsidiary and receipt of a business license. It references compliance with Regulation 30 of SEBI (LODR) Regulations, 2015, which pertains to continuous disclosures about material events. The document is brief (2015 characters) and serves as an announcement or intimation rather than a detailed report or financial statement. It does not contain financial data, audit information, or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-10-14 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the loss of share certificates and the consequent stop transfer of shares until duplicate certificates are issued. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 39(3), which pertains to share certificate loss and stop transfer procedures. The content is an intimation or notification about a corporate action related to share certificates, not a financial report, earnings release, or management discussion. It does not contain financial data, audit information, or meeting materials. The document is a regulatory compliance announcement related to share transfer and certificate loss, fitting best under Regulatory Filings (RNS) as it does not fit other more specific categories.
2023-10-12 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, issued by the Registrar and Transfer Agent for the quarter ended 30th September 2023. It is a compliance certificate confirming regulatory adherence rather than a full financial report or detailed filing. The document length is short (1985 characters) and it serves as a regulatory compliance certificate rather than a report itself. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance certificates and miscellaneous regulatory announcements.
2023-10-09 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding the issuance of duplicate share certificates to shareholders due to loss or misplacement of original certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate issuance and compliance. The content is an intimation or notification about a corporate action related to share certificates, not a financial report, earnings release, or management discussion. It is not a report itself but an official announcement of a corporate compliance action. The document length is short (2259 characters), and it serves as a regulatory notification to exchanges. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous compliance announcements that do not fit other specific categories.
2023-10-05 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.